Jana Partners’s Exact Sciences EXAS Stock Holding History

Jana Partners’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-750,000	Closed	-$47.3M	–	20
2018 Q4	$47.3M	Buy	+750,000	New	+$51.5M	2.16%	15

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Jana Partners's EXAS Position: Q1 2019 in Review

Jana Partners sold out of Exact Sciences (EXAS) in Q1 2019, closing a stake of 733,069 shares — an estimated $46.3M sold.

Jana Partners first reported a position in EXAS in Q3 2018 and held it in 2 quarters. The position peaked at $91.8M in Q3 2018. 424 funds tracked by Wall St. Rank hold EXAS as of Q1 2019.

Jana Partners reported no remaining Exact Sciences position as of Q1 2019 after selling out during the quarter.
Jana Partners sold 733,069 Exact Sciences shares in Q1 2019, an estimated $46.3M.
Jana Partners first reported a position in Exact Sciences in Q3 2018 and held it in 2 quarters.
Jana Partners's Exact Sciences position peaked at $91.8M in Q3 2018.
424 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2019.

Based on Jana Partners's 13F filing for Q1 2019, filed 15 May 2019.